Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mona Fouad"'
Publikováno v:
Future Oncology. 12:413-425
Background: We performed a meta-analysis of the risk of endocrine adverse events associated with immune check point inhibitors. Methods: Eligible studies included randomized trials of cancer patients on immune checkpoint inhibitors; describing events
Publikováno v:
Future Oncology. 11:2471-2484
Background: We performed a meta-analysis of the risk of cutaneous toxicities associated with immune checkpoint inhibitors. Methods: Eligible studies included randomized trials of patients with solid tumors on immune checkpoint inhibitors (ipilimumab,
Autor:
Mona Fouad, Omar Abdel-Rahman
Publikováno v:
Current Medical Research and Opinion. 31:975-986
We performed a systematic review and meta-analysis to determine the risk of mucocutaneous adverse events associated with lapatinib.Eligible studies included randomized phase II and III trials of patients with solid tumors on lapatinib; describing eve
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Expert Review of Anticancer Therapy. 15:465-475
We performed a meta-analysis of diarrhea and stomatitis associated with erlotinib use in patients with advanced non-small cell lung cancer. Eligible studies included randomized trials of patients with non-small cell lung cancer on erlotinib describin
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Expert Review of Anticancer Therapy. 15:477-486
We performed a meta-analysis of fatigue associated with the use of everolimus, temsirolimus or ridaforolimus in patients with solid tumors. Eligible studies included randomized trials of patients with solid tumors on everolimus, temsirolimus or ridaf
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Expert review of anticancer therapy. 15(7)
The authors performed a systematic review and meta-analysis of diarrhea and stomatitis associated with the use of everolimus, temsirolimus or ridaforolimus in patients with solid tumors.Eligible studies included randomized trials of patients with sol
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Future oncology (London, England). 11(1)
ABSTRACT Background: We performed a systematic review and meta-analysis of fatigue, hepatic and metabolic toxicities associated with everolimus intake in patients with solid tumors. Methods: Eligible studies included randomized trials of patients wit
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Expert review of anticancer therapy. 14(12)
We performed a systematic review and meta-analysis of mucocutaneous toxicities associated with the use of everolimus in solid tumors.Eligible studies included randomized Phase II and III trials of patients with solid tumors on everolimus; describing
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Expert review of anticancer therapy. 14(10)
We performed a pooled analysis of randomized controlled studies evaluating selected gastrointestinal adverse events associated with lapatinib use in breast cancer patients. Eligible studies included randomized Phase II and III trials of patients with
Autor:
Omar Abdel-Rahman, Mona Fouad
Publikováno v:
Expert opinion on drug safety. 13(8)
A systematic review and meta-analysis of fatigue and hepatic adverse events associated with lapatinib use in solid tumor patients were performed.Eligible studies included randomized Phase II and III trials of patients with solid tumors taking lapatin